CoreWeave (CRWV) officer files Form 4 on Rule 10b5-1 stock sales

Rhea-AI Filing Summary

CoreWeave, Inc. disclosed that its Chief Development Officer, reporting through a Form 4, oversaw multiple small sales of Class A common stock on December 15, 2025. The shares were sold indirectly through the Canis Major SM Trust, an irrevocable trust for the reporting person’s minor child, under a Rule 10b5-1 trading plan adopted on September 2, 2025.

The reported sale prices were weighted averages for transactions executed in ranges from $72.19 to $79.06. After these transactions, the trust held 58,500 shares of Class A common stock, and the reporting person’s child held an additional 1,800 shares of Class A common stock of record.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McBee Brannin

(Last) (First) (Middle)

C/O COREWEAVE, INC.

290 WEST MT. PLEASANT AVENUE, SUITE 4100

(Street)

LIVINGSTON NJ 07039

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CoreWeave, Inc. [ CRWV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Development Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/15/2025		S(1)		202	D	$72.524(2)	58,798	I	Canis Major SM Trust(3)
Class A Common Stock	12/15/2025		S(1)		222	D	$73.7295(4)	58,576	I	Canis Major SM Trust(3)
Class A Common Stock	12/15/2025		S(1)		31	D	$74.5374(5)	58,545	I	Canis Major SM Trust(3)
Class A Common Stock	12/15/2025		S(1)		18	D	$76.355(6)	58,527	I	Canis Major SM Trust(3)
Class A Common Stock	12/15/2025		S(1)		18	D	$78.855(7)	58,509	I	Canis Major SM Trust(3)
Class A Common Stock	12/15/2025		S(1)		9	D	$79.69	58,500	I	Canis Major SM Trust(3)
Class A Common Stock								1,800	I	See Footnote(8)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.19 to $73.01, inclusive.

3. The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee.

4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.20 to $74.16, inclusive.

5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.30 to $74.94, inclusive.

6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.97 to $76.74, inclusive.

7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.65 to $79.06, inclusive.

8. The reported securities are directly held of record by the reporting person's child.

Remarks:

This Form 4 is Part 3 of 3 for this reporting person. Transactions by the reporting person reported on Table I are continued on this Part 3.

	/s/ Nisha Antony, as Attorney-in-Fact	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CoreWeave (CRWV) report in this Form 4 filing?

The filing reports that CoreWeave’s Chief Development Officer had multiple small sales of Class A common stock on December 15, 2025, indirectly through a family trust and a minor child’s account.

How many CoreWeave (CRWV) shares are held after the reported transactions?

After the reported transactions, the Canis Major SM Trust held 58,500 shares of CoreWeave Class A common stock, and the reporting person’s child held 1,800 shares of Class A common stock of record.

Were the CoreWeave (CRWV) stock sales made under a Rule 10b5-1 plan?

Yes. The filing states that the reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.

What price ranges were involved in the CoreWeave (CRWV) stock sales?

The filing reports weighted average sale prices, with individual transactions executed in ranges from $72.19 to $73.01, $73.20 to $74.16, $74.30 to $74.94, $75.97 to $76.74, and $78.65 to $79.06.

Who legally holds the CoreWeave (CRWV) shares described in the Form 4?

The reported securities are held indirectly: most shares are held by the Canis Major SM Trust, an irrevocable trust for the reporting person’s minor child, and additional shares are held of record directly by the reporting person’s child.

What is the relationship of the reporting person to CoreWeave (CRWV)?

The reporting person is an officer of CoreWeave, serving as Chief Development Officer, and is not identified as a director or 10% owner in the check-box section.